Baxter International Inc. — Company profile
Healthcare · Medical Instruments & Supplies · United States
Last price 23 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.90B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Details
| Name | Baxter International Inc. |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 37500 |
| Founded | 1931 |
| Ceo | Andrew Hider |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US0718131099 |
| Cusip | 071813109 |
| Cik | 0000010456 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Andrew P. Hider | Chief Executive Officer, Pres., Interim Group Pres. of Medical Products and Therapies and Director |
| David S. Rosenbloom | Executive Vice President and General Counsel |
| Maria Soriano | Group President of Infusion Therapies and Platforms |
| John Terence Rogers | Executive Vice President and Chief Financial Officer |
| Bernie Heine | Interim Chief Accounting Officer and Controller |
| Charles Patel | Senior Vice President and Chief Information Officer |
| Kevin Moran | Vice President and Head of Investor Relations |
| Stacey Eisen | SVice President, Chief Communications Officer and Corporate Marketing and President of Baxter Foundation |
| Cynthia Carlisle | Executive Vice President and Chief Human Resources Officer |
| James W. Borzi | Executive Vice President and Chief Supply Chain Officer |
Contact
| Address | One Baxter Parkway, Deerfield, Illinois 60015, United States |
| Phone | 224 948 2000 |
| Website | https://www.baxter.com |